SISVEL
At IBC today, Sisvel announced the launch of a new joint patent licensing program, or patent pool, offering a license under patents essential to the DVB-S2X standard, an extension of the DVB-S2 specification that provides additional technologies and features. The program has been launched with a portfolio of essential patents owned or controlled by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V., Hughes Network Systems, LLC, Newtec Cy N.V., RAI - Radiotelevisione Italiana S.p.A., The European Space Agency and WORK Microwave GmbH.
Further information about the terms and conditions of Sisvel’s DVB-S2X licenses is available at http://www.sisvel.com/licensing-programs/digital-video-display-technology/dvb-S2X/license-terms or from Sisvel upon request by companies currently requiring a license.
You may contact Sisvel at the following e-mail address: DVB-S2X@sisvel.com .
The portfolio license makes essential DVB-S2X patents more easily accessible and ensures that all users of this technology will benefit from the transparency and the convenience of the license terms available under this new program.
Davide Ferri, CEO of Sisvel Spa and Sisvel Technology, said “Sisvel and the patent owners have made a consistent effort to launch the DVB-S2X licensing program at this early stage of the technology adoption, thus providing the market with certainty and predictability for the cost of a license. We are therefore very proud of this remarkable achievement”.
Mattia Fogliacco, CEO of the Sisvel Group, said “The EU Commission, in its communication of the 29th of November 2017 setting out the approach to Standard Essential Patents, clearly expressed its support for patent pools and licensing platforms, as being able to ‘address many of the SEP licensing challenges by offering better scrutiny on essentiality, more clarity on aggregate licensing fees and one-stop- shop solutions’ . Sisvel is fully aligned with this statement and is confident that this new program will promote a rapid adoption of the DVB-S2X standard”.
The joint DVB-S2X licensing program remains open to additional patent owners, and Sisvel invites all parties with patents believed to be essential to the DVB-S2X standard to contact Sisvel and submit those patent(s) for an evaluation of essentiality by the program’s designated, independent evaluator.
About DVB-S2X
DVB-S2X is a technical standard developed by the DVB Project and adopted by the European Telecommunications Standardization Institute (“ETSI”) as formally specified in the ETSI document EN 302 307 Part 2, with DVB-S2 being part 1. DVB-S2X is an extension of the DVB-S2 specification and offers improved performance and features for the core applications of DVB-S2, including Direct to Home (DTH), contribution, VSAT and DSNG.
For additional technical information relating to the DVB-S2X standard, visit: www.dvb.org .
About Sisvel
Sisvel is a world leader in fostering innovation and managing intellectual property. The Group identifies, evaluates and maximizes the value of IP assets for its partners around the world, providing firms with a revenue stream which can be reinvested in innovation for the generation of future revenues. Founded in 1982, the Group is headquartered in Luxembourg and has subsidiaries in China, Germany, Italy, Japan, the United States and the United Kingdom.
Sisvel has a long history of managing successful patent portfolios including those related to the audio compression standards known as MP3 and MPEG Audio, as well as broadcasting and receiving of digital terrestrial television standards maintained by the DVB Project. Sisvel currently operates patent pools and joint licensing programs in the fields of mobile communication, Sisvel Mobile Communication Program; wireless local area networking 802.11, Sisvel 802.11 Wi-Fi Joint Licensing Program; digital video broadcasting, Sisvel DVB-T2 Joint Licensing Program; recommendation engines, Sisvel Recommendation Engine Licensing Program; and broadband access to data networks, Sisvel DSL Licensing Program.
For additional information, please visit: www.sisvel.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180917005246/en/
Contact:
Sisvel Group Giulia Dini, +44 203 053 6930 Communications Manager giulia.dini@sisvel.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom